Merck, SpringWorks receive German antitrust approval for their deal
MLex Summary: Drugmakers Merck and SpringWorks Therapeutics received antitrust approval for their deal from the German competition authority on May 20, according to a SpringWorks filing with the US Securities and...To view the full article, register now.
Already a subscriber? Click here to view full article